Concepedia

Linda Zander Balderud

LZ

Statistics

Publications

5

Citations

158

H-Index

5

Active since

2004

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

University of Gothenburg

Linda Zander Balderud is an author at AstraZeneca (Sweden) specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2004–2014

5

Publications

5

Pivotal Advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation

Susanne Koethe, Linda Zander Balderud, Sofia Köster et al. · Journal of Leukocyte Biology · 2011 · 51 citations

, , +12

Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment

Linda Zander Balderud, Mats Bemark · DNA repair · 2004 · 41 citations

, , +11

Annotating Human P‐Glycoprotein Bioassay Data

Barbara Zdrazil, Marta Pinto, Vasanthanathan Poongavanam et al. · Molecular Informatics · 2012 · 32 citations · Full text

, , +17

On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors

Mari Hansson, John Pemberton, Ola Engkvist et al. · SLAS DISCOVERY · 2013 · 20 citations · Full text

, , +13

Using the BioAssay Ontology for Analyzing High-Throughput Screening Data

Linda Zander Balderud, David C. Murray, Niklas Larsson et al. · SLAS DISCOVERY · 2014 · 14 citations · Full text

, , +17

1–5 of 5